News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
TANG CAPITAL PARTNERS LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/05/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/28/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/17/2023 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 10.2% stake in Jounce Therapeutics, Inc. |
| 08/24/2022 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 0% stake in La Jolla Pharmaceutical Company |
| 07/11/2022 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 38.6% stake in La Jolla Pharmaceutical Company |
| 12/02/2021 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 34.9% stake in La Jolla Pharmaceutical Company |
| 11/26/2021 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 0% stake in Aptevo Therapeutics Inc. |
| 11/22/2021 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 18.8% stake in Aptevo Therapeutics Inc. |
| 11/19/2021 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 33.7% stake in Odonate Therapeutics, Inc. |
| 06/21/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/27/2021 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 35.7% stake in La Jolla Pharmaceutical Company |
| 02/09/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/29/2020 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 41.6% stake in Odonate Therapeutics, Inc. |
| 11/18/2020 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 42.5% stake in Aptevo Therapeutics Inc. |
| 09/11/2020 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 35.4% stake in La Jolla Pharmaceutical Company |
| 09/01/2020 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 40.6% stake in Odonate Therapeutics, Inc. |
| 08/18/2020 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 34.4% stake in La Jolla Pharmaceutical Company |
| 06/05/2020 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 32.9% stake in La Jolla Pharmaceutical Company |
| 01/14/2020 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 30.2% stake in La Jolla Pharmaceutical Company |
| 01/07/2020 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 9.5% stake in HERON THERAPEUTICS, INC. /DE/ |
| 06/28/2019 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 47.6% stake in Odonate Therapeutics, Inc. |
| 03/12/2019 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 52.9% stake in Odonate Therapeutics, Inc. |
| 01/14/2019 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 19.9% stake in La Jolla Pharmaceutical Company |
| 11/09/2018 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 51.6% stake in Odonate Therapeutics, Inc. |
| 09/13/2018 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 9.7% stake in HERON THERAPEUTICS, INC. /DE/ |
| 03/01/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/22/2017 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 2.8% stake in Cyclacel Pharmaceuticals, Inc. |
| 03/06/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 02/27/2017 |
SC 13D/A
| Cyclacel Pharmaceuticals, Inc. reports a 13.2% stake in Cyclacel Pharmaceuticals, Inc. |
| 01/24/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 04/14/2016 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 17.4% stake in Heron Therapeutics, Inc. |
| 05/09/2013 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 23.4% stake in A.P. Pharma, Inc. |
| 07/30/2012 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 23.6% stake in A.P. Pharma, Inc. |
|
|
|